Literature DB >> 9788889

Nitric oxide and peroxynitrite production in ocular inflammation.

J B Allen1, T Keng, C Privalle.   

Abstract

Recent studies have implicated nitric oxide and peroxynitrite in the pathogenesis of many diseases, such as septic shock, arthritis, lung disease, and atherosclerosis. Nitric oxide (.NO) exerts many diverse effects on vascular tone, affecting neurotransmission and cellular cytotoxicity/communication. Our laboratory and others have documented a proinflammatory role for .NO in ocular inflammation. Uveitis, which is an inflammation of the highly vascular uveal tract in the eye, is a debilitating condition that can lead to visual impairment and blindness. It is characterized by acute, recurrent, or persistent inflammation with disruption of the blood-aqueous barrier and is accompanied by protein leakage and leukocyte infiltration into the aqueous humor and anterior chamber. Systemic injection of endotoxin into mice and rats, or intraocular injection of endotoxin into mice, rats, and rabbits induces acute uveitis, which clinically and histologically resembles acute anterior uveitis in humans. These models facilitate the study of pathogenic mechanisms that contribute to ocular inflammation. In addition to .NO, superoxide anion radicals (O2.-), and peroxynitrite (ONOO-), the products of the reaction between .NO and O2.-, are also implicated in uveitis. The role of peroxynitrite in ocular inflammation is still largely unknown. Characterization of the roles of these important uveitic mediators in the ocular inflammatory response will provide information critical to the understanding of the pathogenesis of intraocular inflammation so that more effective therapeutic intervention(s) can be developed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9788889      PMCID: PMC1533362          DOI: 10.1289/ehp.98106s51145

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  63 in total

Review 1.  Mammalian nitric oxide synthases.

Authors:  D J Stuehr; O W Griffith
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1992

2.  Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase.

Authors:  D S Bredt; P M Hwang; C E Glatt; C Lowenstein; R R Reed; S H Snyder
Journal:  Nature       Date:  1991-06-27       Impact factor: 49.962

Review 3.  Nitric oxide synthase structure and mechanism.

Authors:  M A Marletta
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

4.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

5.  Kupffer cell:hepatocyte cocultures release nitric oxide in response to bacterial endotoxin.

Authors:  T R Billiar; R D Curran; F K Ferrari; D L Williams; R L Simmons
Journal:  J Surg Res       Date:  1990-04       Impact factor: 2.192

Review 6.  Nitric oxide in the eye: multifaceted roles and diverse outcomes.

Authors:  F Becquet; Y Courtois; O Goureau
Journal:  Surv Ophthalmol       Date:  1997 Jul-Aug       Impact factor: 6.048

7.  Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion.

Authors:  T B McCall; N K Boughton-Smith; R M Palmer; B J Whittle; S Moncada
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

8.  Nitric Oxide in Arthritis

Authors: 
Journal:  Methods       Date:  1996-08       Impact factor: 3.608

9.  Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide.

Authors:  R B Lorsbach; W J Murphy; C J Lowenstein; S H Snyder; S W Russell
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

10.  Peroxynitrite, a product of superoxide and nitric oxide, produces coronary vasorelaxation in dogs.

Authors:  S Liu; J S Beckman; D D Ku
Journal:  J Pharmacol Exp Ther       Date:  1994-03       Impact factor: 4.030

View more
  3 in total

1.  Methyl-1-hydroxy-2-naphthoate, a novel naphthol derivative, inhibits lipopolysaccharide-induced inflammatory response in macrophages via suppression of NF-κB, JNK and p38 MAPK pathways.

Authors:  Jun-Yan Zhang; Hong Jin; Guang-Fa Wang; Peng-Jiu Yu; Shao-Yu Wu; Zheng-Guang Zhu; Zhong-Huang Li; Yuan-Xin Tian; Wei Xu; Jia-Jie Zhang; Shu-Guang Wu
Journal:  Inflamm Res       Date:  2011-06-11       Impact factor: 4.575

2.  Peroxynitrite upregulates angiogenic factors VEGF-A, BFGF, and HIF-1α in human corneal limbal epithelial cells.

Authors:  Negin Ashki; Ann M Chan; Yu Qin; Wei Wang; Meagan Kiyohara; Lin Lin; Jonathan Braun; Madhuri Wadehra; Lynn K Gordon
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-19       Impact factor: 4.799

3.  Protective role of oral antioxidant supplementation in ocular surface of diabetic patients.

Authors:  V Peponis; M Papathanasiou; A Kapranou; C Magkou; A Tyligada; A Melidonis; T Drosos; N M Sitaras
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.